CareMax Q2 Adj EPS $(0.14) Misses $(0.07) Estimate, Sales $224.44M Beat $188.11M Estimate
Portfolio Pulse from saritha@benzinga.com
CareMax reported Q2 adjusted EPS of $(0.14), missing the estimate of $(0.07) by 100%. However, the company's sales of $224.44M beat the estimate of $188.11M by 19.31%. This represents a 27.27% decrease in EPS and a 30.28% increase in sales compared to the same period last year.
August 09, 2023 | 10:59 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CareMax's Q2 earnings missed estimates, but sales exceeded expectations. This mixed result could lead to uncertainty in the market.
CareMax's earnings miss could negatively impact the stock, but the sales beat could offset this. The net effect on the stock price is uncertain in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100